| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.
Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.
Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R.
Harm Reduct J. 2025 Jul 4;22(1):116. doi: 10.1186/s12954-025-01262-4. PMID: 40615907; PMCID: PMC12228173.